TIZANIDINE HYDROCHLORIDE
Manufacturer: Bryant Ranch Prepack
Score: 142.0
Tizanidine hydrochloride is a central alpha-2-adrenergic agonist used for the management of spasticity. It is available in capsule form and should be taken with or without food, with a recommended starting dose of 2 mg and a maximum daily dose of 36 mg. The drug has several contraindications, including use with potent inhibitors of CYP1A2, and may cause adverse reactions such as dry mouth, somnolence, and dizziness. Special population considerations include use during pregnancy, nursing mothers, pediatric use, and geriatric use, with careful monitoring and dose adjustments recommended as needed.
Concomitant use with potent inhibitors of CYP1A2 is contraindicated
Dose adjustments should be made gradually, with careful monitoring of the patient's response to therapy
2 mg, repeated at 6 to 8 hour intervals, up to a maximum of 3 doses in 24 hours
Not established